Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.
Identifieur interne : 001093 ( PubMed/Curation ); précédent : 001092; suivant : 001094Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.
Auteurs : Seung Yun Yim [Corée du Sud] ; Eunjung Ryu ; Jae-Young Lim ; Eun Joo Yang ; Seung-Min LeeSource :
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [ 1433-7339 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Apolipoprotéines E (sang), Biopsie de noeud lymphatique sentinelle, Femelle, Fibronectines (sang), Humains, Lymphadénectomie (effets indésirables), Lymphoedème (anatomopathologie), Lymphoedème (sang), Noeuds lymphatiques (), Noeuds lymphatiques (anatomopathologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Survivants, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (sang).
- MESH :
- anatomopathologie : Lymphoedème, Noeuds lymphatiques, Tumeurs du sein.
- effets indésirables : Lymphadénectomie.
- sang : Apolipoprotéines E, Fibronectines, Lymphoedème, Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Noeuds lymphatiques, Sujet âgé, Sujet âgé de 80 ans ou plus, Survivants, Tumeurs du sein.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Apolipoproteins E (blood), Breast Neoplasms (blood), Breast Neoplasms (pathology), Breast Neoplasms (surgery), Female, Fibronectins (blood), Humans, Lymph Node Excision (adverse effects), Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphedema (blood), Lymphedema (pathology), Middle Aged, Sentinel Lymph Node Biopsy, Survivors.
- MESH :
- chemical , blood : Apolipoproteins E, Fibronectins.
- adverse effects : Lymph Node Excision.
- blood : Breast Neoplasms, Lymphedema.
- pathology : Breast Neoplasms, Lymph Nodes, Lymphedema.
- surgery : Breast Neoplasms, Lymph Nodes.
- Adult, Aged, Aged, 80 and over, Female, Humans, Middle Aged, Sentinel Lymph Node Biopsy, Survivors.
Abstract
Lymphedema is an irreversible disorder often seen as a postoperative side effect in breast cancer survivors. We aimed to identify serum factors that are associated with lymphedema risk in breast cancer survivors.
DOI: 10.1007/s00520-014-2588-2
PubMed: 25577503
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001093
Links to Exploration step
pubmed:25577503Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.</title><author><name sortKey="Yim, Seung Yun" sort="Yim, Seung Yun" uniqKey="Yim S" first="Seung Yun" last="Yim">Seung Yun Yim</name><affiliation wicri:level="1"><nlm:affiliation>Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul</wicri:regionArea></affiliation></author><author><name sortKey="Ryu, Eunjung" sort="Ryu, Eunjung" uniqKey="Ryu E" first="Eunjung" last="Ryu">Eunjung Ryu</name></author><author><name sortKey="Lim, Jae Young" sort="Lim, Jae Young" uniqKey="Lim J" first="Jae-Young" last="Lim">Jae-Young Lim</name></author><author><name sortKey="Yang, Eun Joo" sort="Yang, Eun Joo" uniqKey="Yang E" first="Eun Joo" last="Yang">Eun Joo Yang</name></author><author><name sortKey="Lee, Seung Min" sort="Lee, Seung Min" uniqKey="Lee S" first="Seung-Min" last="Lee">Seung-Min Lee</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25577503</idno><idno type="pmid">25577503</idno><idno type="doi">10.1007/s00520-014-2588-2</idno><idno type="wicri:Area/PubMed/Corpus">001093</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001093</idno><idno type="wicri:Area/PubMed/Curation">001093</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001093</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.</title><author><name sortKey="Yim, Seung Yun" sort="Yim, Seung Yun" uniqKey="Yim S" first="Seung Yun" last="Yim">Seung Yun Yim</name><affiliation wicri:level="1"><nlm:affiliation>Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul</wicri:regionArea></affiliation></author><author><name sortKey="Ryu, Eunjung" sort="Ryu, Eunjung" uniqKey="Ryu E" first="Eunjung" last="Ryu">Eunjung Ryu</name></author><author><name sortKey="Lim, Jae Young" sort="Lim, Jae Young" uniqKey="Lim J" first="Jae-Young" last="Lim">Jae-Young Lim</name></author><author><name sortKey="Yang, Eun Joo" sort="Yang, Eun Joo" uniqKey="Yang E" first="Eun Joo" last="Yang">Eun Joo Yang</name></author><author><name sortKey="Lee, Seung Min" sort="Lee, Seung Min" uniqKey="Lee S" first="Seung-Min" last="Lee">Seung-Min Lee</name></author></analytic><series><title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title><idno type="eISSN">1433-7339</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Apolipoproteins E (blood)</term><term>Breast Neoplasms (blood)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Female</term><term>Fibronectins (blood)</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Nodes (pathology)</term><term>Lymph Nodes (surgery)</term><term>Lymphedema (blood)</term><term>Lymphedema (pathology)</term><term>Middle Aged</term><term>Sentinel Lymph Node Biopsy</term><term>Survivors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Apolipoprotéines E (sang)</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Fibronectines (sang)</term><term>Humains</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (anatomopathologie)</term><term>Lymphoedème (sang)</term><term>Noeuds lymphatiques ()</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survivants</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (sang)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Apolipoproteins E</term><term>Fibronectins</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term><term>Noeuds lymphatiques</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymph Nodes</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Apolipoprotéines E</term><term>Fibronectines</term><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term><term>Lymph Nodes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Sentinel Lymph Node Biopsy</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Noeuds lymphatiques</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survivants</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is an irreversible disorder often seen as a postoperative side effect in breast cancer survivors. We aimed to identify serum factors that are associated with lymphedema risk in breast cancer survivors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25577503</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>27</Day></DateCreated><DateCompleted><Year>2015</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-7339</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.</ArticleTitle><Pagination><MedlinePgn>2319-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-014-2588-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Lymphedema is an irreversible disorder often seen as a postoperative side effect in breast cancer survivors. We aimed to identify serum factors that are associated with lymphedema risk in breast cancer survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study recruited 60 volunteer breast cancer survivors. Participants were classified into either a CTRL group who underwent sentinel lymph node biopsy (SLNB), a RISK group who underwent axillary lymph node dissection (ALND) with removal of fewer than five lymph nodes, or an LE group who underwent ALND with removal of more than five lymph nodes. Bioimpedance was measured to determine the ratio of extracellular water (ECW) to total cellular water (TCW) and single-frequency bioimpedance analysis (SFBIA) ratios. Serum lipid profiles were compared among the groups using label-free quantitative proteomics with the nano-liquid chromatography (LC)-tandem mass spectrometer (MS/MS) and emPAI method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CTRL, RISK, and LE groups had similar body weights and body mass indexes (BMIs) (<25 kg/m(2)). The LE group showed a higher grade of lymphedema severity compared to the RISK and CTRL groups. Lymphedema indices such as the ECW/TCW ratio and SFBIA ratio at 1 and 5 kHz were greatly increased in the LE group. Serum total cholesterol (total-C) level was higher in the LE group without affecting atherogenic index. Serum proteomics revealed that fibronectin 1 (FN1), apolipoprotein E (ApoE), antithrombin (ANT3), and complement C4 had different abundance values among the groups. ELISA confirmed that FN1 and ApoE were significantly elevated in both the RISK and LE groups compared to the CTRL group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Changes in serum FN1 and ApoE levels were detected prior to changes in serum total-C level and lymphedema indices such as SFBIA ratio. Therefore, elevation in serum FN1 and ApoE concentrations could likely be used to monitor the risk of lymphedema in breast cancer survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yim</LastName><ForeName>Seung Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Eunjung</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jae-Young</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Eun Joo</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung-Min</ForeName><Initials>SM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501742">FN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005353">Fibronectins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005353" MajorTopicYN="N">Fibronectins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25577503</ArticleId><ArticleId IdType="doi">10.1007/s00520-014-2588-2</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001093 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001093 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25577503
|texte= Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25577503" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |